AAAAAA
Results: 26-39/39
Authors:
Salnikow, K
Costa, M
Figg, WD
Blagosklonny, MV
Citation: K. Salnikow et al., Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer, CANCER RES, 60(20), 2000, pp. 5630-5634
Authors:
Salnikow, K
Su, WC
Blagosklonny, MV
Costa, M
Citation: K. Salnikow et al., Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism, CANCER RES, 60(13), 2000, pp. 3375-3378
Authors:
Blagosklonny, MV
Bishop, PC
Robey, R
Fojo, T
Bates, SE
Citation: Mv. Blagosklonny et al., Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cells, CANCER RES, 60(13), 2000, pp. 3425-3428
Authors:
Salnikow, K
Blagosklonny, MV
Ryan, H
Johnson, R
Costa, M
Citation: K. Salnikow et al., Carcinogenic nickel induces genes involved with hypoxic stress, CANCER RES, 60(1), 2000, pp. 38-41
Authors:
Sandor, V
Senderowicz, A
Mertins, S
Sackett, D
Sausville, E
Blagosklonny, MV
Bates, SE
Citation: V. Sandor et al., P21-dependent G(1) arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228, BR J CANC, 83(6), 2000, pp. 817-825
Authors:
Bergan, RC
Reed, E
Myers, CE
Headlee, D
Brawley, O
Cho, HK
Figg, WD
Tompkins, A
Linehan, WM
Kohler, D
Steinberg, SM
Blagosklonny, MV
Citation: Rc. Bergan et al., A phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer, CLIN CANC R, 5(9), 1999, pp. 2366-2373
Authors:
Blagosklonny, MV
An, WG
Melillo, G
Nguyen, P
Trepel, JB
Neckers, LM
Citation: Mv. Blagosklonny et al., Regulation of BRCA1 by protein degradation, ONCOGENE, 18(47), 1999, pp. 6460-6468
Authors:
Blagosklonny, MV
Chuman, Y
Bergan, RC
Fojo, T
Citation: Mv. Blagosklonny et al., Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells, LEUKEMIA, 13(7), 1999, pp. 1028-1036
Authors:
Blagosklonny, MV
Citation: Mv. Blagosklonny, Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversal, LEUKEMIA, 13(12), 1999, pp. 2031-2035
Authors:
Blagosklonny, MV
Citation: Mv. Blagosklonny, A node between proliferation, apoptosis, and growth arrest, BIOESSAYS, 21(8), 1999, pp. 704-709
Authors:
Kruger, EA
Blagosklonny, MV
Dixon, SC
Figg, WD
Citation: Ea. Kruger et al., UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic response, INVAS METAS, 18(4), 1999, pp. 209-218
Authors:
Salnikow, K
An, WG
Melillo, G
Blagosklonny, MV
Costa, M
Citation: K. Salnikow et al., Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors, CARCINOGENE, 20(9), 1999, pp. 1819-1823
Authors:
Romanova, LY
Alexandrov, IA
Blagosklonny, MV
Nordan, RP
Garfield, S
Acs, P
Nguyen, P
Trepel, J
Blumberg, PM
Mushinski, JF
Citation: Ly. Romanova et al., Regulation of actin cytoskeleton in lymphocytes: PKC-delta disrupts IL-3-induced membrane ruffles downstream of Rac1, J CELL PHYS, 179(2), 1999, pp. 157-169
Authors:
Blagosklonny, MV
Fojo, T
Citation: Mv. Blagosklonny et T. Fojo, Molecular effects of paclitaxel: Myths and reality (a critical review), INT J CANC, 83(2), 1999, pp. 151-156